Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 7, 2002, Pages 759-764

  Djurovic, Srdjan ^a,b   Clausen, Torun ^c   Wergeland, Ragnhild ^d   Brosstad, Frank ^d   Berg, Kåre ^a,b   Henriksen, Tore ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EDETIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; PARITY; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNIVERSITY HOSPITAL; VENOUS BLOOD; WILCOXON SIGNED RANKS TEST; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; PREGNANCY; PREGNANCY COMPLICATION;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036636263     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2002.01330.x     Document Type: Article

References (37)

1. Walker J. Pre-eclampsia. Lancet. 356:2000;1260-1265.
2. Roberts J.M., Cooper D.W. Pathogenesis and genetics of preeclampsia. Lancet. 357:2001;53-56.
3. Sacks G.P., Studena K., Sargent K., Redman C.W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 179:1998;80-86.
4. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 180:1999;499-506.
5. Redman C.W., Sargent I.L. Placental debris, oxidative stress and pre-eclampsia. Placenta. 21:2000;597-602.
6. Øian P., Omsjø I., Maltau J.M., Østerud B. Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients. Br J Obstet Gynaecol. 92:1985;511-517.
7. Greer I.A., Haddad N.G., Dawes J., Johnstone F.D., Calder A.A. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol. 96:1989;978-982.
8. Haeger M., Unander M., Norder-Hansson B., Tylman M., Bengtsson A. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 79:1992;19-26.
9. Tsukimori K., Maeda H., Ishida K., Nagata H., Koyanagi T., Nakano H. The superoxide generation of neutrophils in normal and pre-eclamptic pregnancies. Obstet Gynecol. 81:1993;536-540.
10. Barden A., Graham D., Beilin LJet al. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci. 92:1997;37-44.
11. Kupferminc M.J., Peaceman A.M., Aderka D., Wallach D., Socol M.L. Soluble tumor necrosis factor and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol. 88:1996;420-427.
12. Greer I.A., Lyall F., Perera T., Boswell F., Macara L.M. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 84:1994;937-940.
13. Vince G.S., Starkey P.M., Austgulen Ret al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol. 102:1995;20-25.
14. Hamai Y., Fujii T., Yamashita Tet al. Evidence for an elevation in serum interleukin-2 and tumor-necrosis factor-alpha in pre-eclampsia. Am J Reprod Immunol. 38:1997;89-93.
15. Conrad K.P., Miles T.M., Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Rep Immunol. 40:1998;102-111.
16. Clausen T., Djurovic S., Brosstad F.R., Berg K., Henriksen T. Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol. 182:2000;321-325.
17. Rangel-Frausto S.M., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R.P. The natural history of the systemic inflammatory response (SIRS) A prospective study. JAMA. 273:1995;117-123.
18. Estellés A., Gilabert J., Aznar J., Loskutoff D.J., Schleef R.R. Changes in plasma levels of type 1 and type 2 plasminogen activator inhibitor in normal pregnancy and in patients with severe preeclampsia. Blood. 74:1989;1332-1338.
19. Reith A., Booth N.A., Moore N.R., Cruickshank D.J., Bennet B. Plasminogen activator inhibitors ( PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatiform mole. Br J Obstet Gynaecol. 100:1993;370-374.
20. Chappell L.C., Seed P.T., Briley ALet al. Effect of antioxidants on the recurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 354:1999;810-816.
21. Camerer E., Kolstø A.B., Prydz H. Cell biology of tissue factor, the principal initiator of coagulation. Thromb Res. 81:1996;1-41.
22. Bellart J., Gilabert R., Angles Aet al. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol. 106:1999;594-597.
23. Agrawal A., Kilpatrick J.M., Volanakis J.E. Structure and function of human C-reactive protein. Mackiewicz A., Kushner I., Baumann H. Acute Phase Proteins. Molecular Biology, Biochemistry, and Clinical Applications. 1993;79-92 CRC Press, Boca Raton, FL.
24. Volanakis J.E. Acute phase proteins in rheumatic disease. Koopman W.J. Arthritis and Allied Conditions: A Textbook of Rheumatology. 13th edition:1997;505-514 Williams & Wilkins, Baltimore.
25. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:2000;836-843.
26. Okerengwo A.A., Williams A.I., Ibeziako P.A. Immunological studies on pre-eclampsia in Nigerian women. Int J Gynaecol Obstet. 33:1990;121-125.
27. Wolf M.S., Kettyle E.P., Ecker J.L., Frigoletto F.D., Thadhani R.I. First trimester high resolution C-reactive protein and risk of hypertensive disorders of pregnancy. J Soc Gynecol Invest. 8(Suppl):2001;278A.
28. Visser W., Beckman I., Bremer H.A., Lim H.L., Wallenburg H.C. Bioactive tumor necrosis factor-α in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol. 101:1994;1081-1082.
29. Schiff E., Friedman S.A., Baumann P., Sibai B.N., Romero R. Tumor necrosis factor-α in pregnancies associated with preeclampsia or small for gestational age newborns. Am J Obstet Gynecol. 170:1994;1224-1229.
30. Greer I.A., Lyall F., Perera T., Boswell F., Macara L.M. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 84:1994;937-940.
31. Meekins J.W., McLaughlin P.J., West DCet al. Endothelial cell activation by tumour necrosis factor-alpha and the development of preeclampsia. Clin Exp Immunol. 98:1994;110-114.
32. Hotamisligil G.S., Arner P., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 95:1995;2409-2415.
33. Williams M.A., Farrand A., Mittendorf Ret al. Maternal second trimester serum tumor necrosis factor-α soluble receptor p55 (s TNFαp55) and subsequent risk of preeclampsia. Am J Epidemiol. 149:1999;323-329.
34. Hennnessy A., Pilmore H.L., Simmons L.A., Painter D.M. A deficiency of placental IL-10 in preeclampsia. J Immunol. 163:1999;3491-3495.
35. Rinehart B.K., Terrone D.A., Lagoo-Deenadayalan Set al. Expression of placental cytokines tumor necrosis factor α, interleukin 1β, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 181:1999;915-920.
36. Benyo Fairchild D.H., Miles T.M., Conrad K.P. Hypoxia stimulates cytokine production in villous explants from human placenta. J Clin Endocrinol Metab. 82:1997;1582-1588.
37. Bosio P.M., Cannon S., McKenna P.J., O'Herlihy C., Conroy R., Brady H. Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia. Br J Obstet Gynaecol. 108:2001;709-715.